Professor David Johnson
MB BS (Hons) (Qld), PhD (Syd), FRACP
David Johnson is currently Director of Renal Medicine at Princess Alexandra Hospital, Brisbane, Australia, Professor of Medicine and Professor of Population Health at University of Queensland, Chair of the Queensland Statewide Renal Clinical Network, Chair of the CARI Guidelines Working Parties on Peritoneal Dialysis Adequacy, Evaluation of Renal Function and Management of early CKD, Chair of the Kidney Check Australia Taskforce, Co-Chair of the Australasian Creatinine and eGFR Consensus Working Party, Co-Chair of the Australasian Proteinuria Consensus Working Party, Founding Member and Deputy Chair of the Australasian Kidney Trials Network (based at Princess Alexandra Hospital), Founding Member of the NHMRC-endorsed Cardiovascular and Renal Centre of Clinical Research Excellence, Member of the ANZDATA Registry Peritoneal Dialysis Working Group and International Society of Peritoneal Dialysis Councillor.
He is the principal investigator on a number of large, multi-centre randomised controlled trials, including the balANZ, IDEAL, HERO, AVATAR, IMPENDIA and HONEYPOT trials. He has published over 400 original manuscripts in peer-reviewed journals and presented over 290 abstracts at national and international scientific meetings. He has won numerous research awards for his clinical and basic science studies in the areas of peritoneal dialysis outcomes, cardiovascular risk factor modification in uraemia, renal transplantation, dialysis unit infection control, treatment of acute renal failure and mechanisms of progressive chronic kidney disease. In 2005, he was awarded the TJ Neale Award by the Australian and New Zealand Society of Nephrology for “outstanding contributions to nephrologic science.” In 2011, he was awarded a Public Service Medal by the Governor-General of Australia for outstanding public service, particularly research into the early detection and management of kidney disease.